Description
The CDC pledges “To base all public health decisions on the highest quality scientific data, openly and objectively derived.” But Peter Doshi argues that in the case of influenza vaccinations and their marketing, this is not so.Citation
Doshi, P. (2013). Influenza: marketing vaccine by marketing disease. BMJ 2013;346:f3037. DOI: https://doi.org/10.1136/bmj.f3037Keyword
Vaccination--trendsInfluenza Vaccines
Influenza, Human--epidemiology
Influenza, Human--prevention & control
Centers for Disease Control and Prevention (U.S.)
Identifier to cite or link to this item
http://hdl.handle.net/10713/6608ae974a485f413a2113503eed53cd6c53
10.1136/bmj.f3037
Scopus Count
Collections
Related articles
- [Influenza vaccination for all older than 65 years--utopia or possibility].
- Authors: Malmvall BE, Abom PE
- Issue date: 2004 Dec 23
- Our national obsession with flu vaccine.
- Authors: Stephens P
- Issue date: 2013 Sep
- Survey of vaccine distribution and delivery issues in the USA: from pediatrics to pandemics.
- Authors: Jacobson SH, Sewell EC, Jokela JA
- Issue date: 2007 Dec
- [The flu: should all be vaccinated?].
- Authors: Cisterna R
- Issue date: 2009 Nov
- Mandating influenza vaccination for healthcare workers.
- Authors: Sullivan SJ, Jacobson R, Poland GA
- Issue date: 2009 Nov